Clopidogrel, genetics, and drug responsiveness.
Freedman
Jane E
JE
Hylek
Elaine M
EM
D054058:Acute Coronary Syndrome / Q000628:therapy*; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics* / Q000378:metabolism; D002318:Cardiovascular Diseases; D000077144:Clopidogrel; D065731:Cytochrome P-450 CYP2C19; D006801:Humans; D009154:Mutation; D009203:Myocardial Infarction / Q000628:therapy*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D011110:Polymorphism, Genetic; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D001189:Aryl Hydrocarbon Hydroxylases; C045793:CYP2C19 protein, human; D065731:Cytochrome P-450 CYP2C19; D013988:Ticlopidine